Peter A. Cohen, M.D.

  1. Internist

Departments

Location

  1. Phoenix, Arizona

Languages

English
  1. 1992
    Fellow - Medical OncologyNational Cancer Institute/Naval Hospital, Bethesda, MD
  2. 1989
    Chief Resident - Internal MedicineSt. Vincent's Hospital, New York City
  3. 1988
    Resident - Internal Medicine, PGY-1 to PGY-3 yearsSt. Vincent's Hospital, New York City
  4. 1983
    Post Doctoral Fellowship - Allergy and Immunology (Dr. David H. Katz)Scripps Clinic and Research Foundation
  5. 1979
    MDDartmouth Medical School
  6. 1972
    AB - Comparative LiteratureDartmouth College

Certifications

  1. 1989
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2011
    Winner, Richard M. Schulze Family Award in Cancer to fund clinical trial of combined immunotherapy/chemotherapyThe Richard M. Schulze Family Foundation
  2. 2007
    Innovator Award: Patent application 11845976: "A method to proliferate and precondition dendritic cell precursors for immunotherapy using Flt3 ligand and interleukin-6 in the absence of GM-CSFCleveland Clinic
  3. 1989
    Highest rated oncology fellowNational Cancer Institute Medical Oncology Program
  4. 1980
    Postdoctoral Fellowship Award "1 F32 AI 06432" for "Regulation of IgE Antibody Synthesis in Animals and Man" with a priority score of 121National Institutes of Health
  5. 1979
    Pathology Department stipend awards for predoctoral research trainingDartmouth Medical School
  6. 1977
    Pathology Department stipend awards for predoctoral research trainingDartmouth Medical School
  7. 1972
    Magna cum Laude with high honors in comparative literatureDartmouth College
  8. 1972
    Marcus Heiman Award for Special Achievement in the Arts (motion picture and classical piano)Dartmouth College
  9. 1970
    Teaching assistantships in French, Italian and cinema studiesDartmouth College
  10. 1968
    Class of 1914 Scholarship awardDartmouth College

Professional memberships

  1. 2012
    Invited Ad Hoc MemberSpecial Emphasis Panel: Lasker Clinical Scholar Review (CSR/NIH), NCI Study Sections
  2. 2012
    Invited Ad Hoc MemberSpecial Translational/Clinical Applications 2nd Tier CSR Review ZRG1 DTCS U(81), NCI Study Sections
  3. 2010 - present
    MemberOffice of Research Resources Committee
  4. 2010 - present
    MemberBreast Cancer Disease-Oriented Group
  5. 2010 - present
    MemberMCA Cancer Center Committee, Mayo Clinic Arizona Committees
  6. 2010 - present
    DirectorMayo Arizona FACS Core Facility
  7. 2009 - present
    MemberPhase I Disease-Oriented Group
  8. 2006 - 2011
    Permanent MemberClinical Immunology and Immunopathology (former ET-2) Study Section for RO-1/R21 applications, NCI Study Sections
  9. 2005
    Invited MemberScott Hamilton CARES Initiatives Review Committee, Taussig Cancer Center, Cleveland Clinic Foundation
  10. 2005
    Invited Member2005/10 ZRG1 ONC-D, Clinical Immunotherapy Ad Hoc Study Section, NCI Study Sections
  11. 2005
    Invited Ad Hoc MemberRO-1/R21 applications, Developmental Therapeutics Study Section, NCI Study Sections
  12. 2005
    Invited ReviewerAvon-NCI Progress for Patients (PFP) Awards Program
  13. 2004
    Invited MemberZRG1 ONC-D (03) (M), Clinical Immunotherapy Ad Hoc Study Section, NCI Study Sections
  14. 2004 - 2005
    Invited MemberClinical Immunology and Immunopathology (former ET-2) Study Section for RO-1/R21 applications, NCI Study Sections
  15. 2004
    Invited ReporterNCI-D Parent Committee, NCI Study Sections
  16. 2004
    Invited Ad Hoc MemberJ. Banchereau, Principal Investigator, Improving the Efficacy of Dendritic Cell Vaccines.", PO1 CA8512-01A1 Competitive Renewal, "
  17. 2003
    Invited Ad Hoc MemberZRG1 CAMP 03 M, Melanoma Targeted Novel Therapy, NCI Scientific Review Group, NCI Study Sections
  18. 2003 - present
    MemberAmerican Association for Cancer Research
  19. 2002
    Invited Ad Hoc MemberPO1 Application resubmission, NCI Study Sections
  20. 2002
    Invited Ad Hoc MemberH. Schreiber, Principal Investigator, University of Chicago/Loyola University, CD8+ T cells and immunological tumor regression"
  21. 2001 - 2008
    MemberRenal SPORE/Program Project Committee, Cleveland Clinic Foundation
  22. 2001 - 2008
    Translational Research CoordinatorRenal SPORE/Program Project Committee, Cleveland Clinic Foundation
  23. 2000 - 2008
    Radiation Safety OfficerCenter for Surgery Research, Cleveland Clinic Foundation
  24. 2000 - present
    MemberOrganizing Committee, Dr. Zou Atassi, Chairman, International Symposium on the Immunobiology of Proteins and Peptides
  25. 1999 - 2008
    MemberResearch Programs Committee, Cancer Center, Cleveland Clinic Foundation
  26. 1999 - 2005
    MemberClinical Trials Scientific Review Committee, Cancer Center, Cleveland Clinic Foundation
  27. 1988 - present
    MemberAmerican College of Physicians
see more

Publications

Research activities

See a description of research activities.